MedPath

Objective Analysis of Caesarean Scar Pregnancy

Completed
Conditions
Caesarean Scar Pregnancy
Ultrasound Scoring System
Interventions
Procedure: ultrasound-guided/hysteroscopic curettage
Registration Number
NCT06276790
Lead Sponsor
Chengde Central Hospital
Brief Summary

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
117
Inclusion Criteria
  • history of at least one previous caesarean section
  • symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
  • amenorrhea ≤84 days
  • ultrasound examination suggesting a single gestational sac with intact morphology
  • stable maternal vital signs
Exclusion Criteria
  • mass-type caesarean scar pregnancy
  • previous medication or surgical treatment before ultrasound examination
  • haemodynamically unstable patients
  • patients with surgical contraindications
  • incomplete or lost follow-up clinical data
  • patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
low-risk groupultrasound-guided/hysteroscopic curettage-
Primary Outcome Measures
NameTimeMethod
intraoperative blood lossduring surgery

The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.

serum β-HCG levelsWithin 2 weeks after the operation

The time taken for serum β-HCG levels to return to normal

length of hospital stayWithin 1 week

Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chengde Central Hospital

🇨🇳

Chengde, China

© Copyright 2025. All Rights Reserved by MedPath